Federica Pericle

2.3k total citations
42 papers, 1.9k citations indexed

About

Federica Pericle is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Federica Pericle has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Federica Pericle's work include Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (14 papers) and CAR-T cell therapy research (9 papers). Federica Pericle is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (14 papers) and CAR-T cell therapy research (9 papers). Federica Pericle collaborates with scholars based in United States, Italy and United Kingdom. Federica Pericle's co-authors include Guido Forni, Federica Cavallo, Vincenzo Bronte, Michela Spadaro, Robert A. Kirken, Nicholas P. Restifo, Michael Wang, Steven A. Rosenberg, Deborah R. Surman and Willem W. Overwijk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Federica Pericle

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Pericle United States 27 1.2k 595 557 272 169 42 1.9k
Ulla M. Sarmiento United States 19 1.5k 1.2× 502 0.8× 696 1.2× 267 1.0× 62 0.4× 27 2.5k
M Kriegler United States 12 812 0.7× 454 0.8× 628 1.1× 357 1.3× 37 0.2× 12 1.6k
Varada P. Rao United States 19 1.2k 0.9× 618 1.0× 537 1.0× 216 0.8× 27 0.2× 20 1.9k
Vicki L. Schweickart United States 17 1.0k 0.8× 934 1.6× 822 1.5× 171 0.6× 66 0.4× 18 2.6k
T Otsuka Japan 21 1.3k 1.1× 386 0.6× 614 1.1× 324 1.2× 22 0.1× 53 2.5k
Nirit Mor‐Vaknin United States 21 421 0.3× 231 0.4× 915 1.6× 106 0.4× 89 0.5× 31 1.8k
Tim Willinger United States 21 1.6k 1.3× 519 0.9× 710 1.3× 311 1.1× 28 0.2× 27 2.6k
Pinaki P. Banerjee United States 25 1.6k 1.3× 656 1.1× 689 1.2× 459 1.7× 135 0.8× 57 2.6k
Natalia Martín‐Orozco United States 22 2.1k 1.7× 968 1.6× 405 0.7× 405 1.5× 51 0.3× 30 2.8k
Michael R. Rubira Australia 13 832 0.7× 412 0.7× 579 1.0× 139 0.5× 40 0.2× 17 1.8k

Countries citing papers authored by Federica Pericle

Since Specialization
Citations

This map shows the geographic impact of Federica Pericle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Pericle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Pericle more than expected).

Fields of papers citing papers by Federica Pericle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Pericle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Pericle. The network helps show where Federica Pericle may publish in the future.

Co-authorship network of co-authors of Federica Pericle

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Pericle. A scholar is included among the top collaborators of Federica Pericle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Pericle. Federica Pericle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rolih, Valeria, Jerri C. Caldeira, Elisabetta Bolli, et al.. (2020). Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers. 12(6). 1492–1492. 28 indexed citations
2.
Ruiu, Roberto, Valeria Rolih, Elisabetta Bolli, et al.. (2018). Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter. Cancer Immunology Immunotherapy. 68(1). 131–141. 43 indexed citations
3.
Moss, Donald E., et al.. (2012). A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease. British Journal of Clinical Pharmacology. 75(5). 1231–1239. 11 indexed citations
4.
Spadaro, Michela, Claudia Curcio, Atul Varadhachary, et al.. (2007). Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in Talactoferrin-Induced Inhibition of neu+ Tumors. Cancer Research. 67(13). 6425–6432. 30 indexed citations
5.
Dow, Steven, et al.. (2005). Phase I Study of Liposome-DNA Complexes Encoding the Interleukin-2 Gene in Dogs with Osteosarcoma Lung Metastases. Human Gene Therapy. 0(0). 698318425–698318425. 1 indexed citations
6.
Quaglino, Elena, Manuela Iezzi, Cristina Mastini, et al.. (2004). Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neuTransgenic Mice. Cancer Research. 64(8). 2858–2864. 127 indexed citations
7.
Varadhachary, Atul, Jeffrey S. Wolf, Karel Petrak, et al.. (2004). Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. International Journal of Cancer. 111(3). 398–403. 104 indexed citations
8.
Bray, David A., Hilary Koprowski, Juong G. Rhee, et al.. (2003). Combination Nonviral Interleukin 2 Gene Therapy and External-Beam Radiation Therapy for Head and Neck Cancer. Archives of Otolaryngology - Head and Neck Surgery. 129(6). 618–618. 12 indexed citations
9.
Matar, Majed, et al.. (2000). Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil. Cancer Gene Therapy. 7(8). 1165–1171. 7 indexed citations
10.
Mendiratta, Sanjeev Kumar, Abraham Quezada, Majed Matar, et al.. (1999). Intratumoral delivery of IL-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity. Gene Therapy. 6(5). 833–839. 59 indexed citations
11.
Sconocchia, Giuseppe, Julie A. Titus, Alessandra Mazzoni, et al.. (1999). CD38 Triggers Cytotoxic Responses in Activated Human Natural Killer Cells. Blood. 94(11). 3864–3871. 62 indexed citations
12.
Pericle, Federica, Lígia A. Pinto, Stuart W. Hicks, et al.. (1998). Cutting Edge: HIV-1 Infection Induces a Selective Reduction in STAT5 Protein Expression. The Journal of Immunology. 160(1). 28–31. 46 indexed citations
13.
Coleman, Michael D., Susanne Müller, Abraham Quezada, et al.. (1998). Nonviral Interferon α Gene Therapy Inhibits Growth of Established Tumors by Eliciting a Systemic Immune Response. Human Gene Therapy. 9(15). 2223–2230. 37 indexed citations
14.
Pericle, Federica, Robert A. Kirken, Vincenzo Bronte, et al.. (1997). Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. The Journal of Immunology. 159(6). 2580–2585. 41 indexed citations
15.
Pericle, Federica, Giuseppe Sconocchia, J A Titus, & David M. Segal. (1996). CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells. The Journal of Immunology. 157(10). 4657–4663. 28 indexed citations
16.
Epling‐Burnette, Pearlie K., Jin Hong Liu, Federica Pericle, et al.. (1995). Expression of interleukin‐2 receptor γ on human monocytes: characterization of lineage specific post‐translational modifications. European Journal of Immunology. 25(1). 291–294. 17 indexed citations
17.
Pericle, Federica, et al.. (1994). Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12. Blood. 83(5). 1323–1328. 70 indexed citations
18.
Pericle, Federica, Jin Hong Liu, D. Kay Blanchard, et al.. (1994). Interleukin‐2 prevention of apoptosis in human neutrophils. European Journal of Immunology. 24(2). 440–444. 101 indexed citations
19.
Pericle, Federica, Mirella Giovarelli, Mario P. Colombo, et al.. (1994). An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.. The Journal of Immunology. 153(12). 5659–5673. 114 indexed citations
20.
Pierro, Francesco Di, Federica Cavallo, Federica Pericle, et al.. (1993). Strategies for cytokine utilisation in tumor therapy. Medical Oncology and Tumor Pharmacotherapy. 10(1-2). 53–59. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulla M. Sarmiento Breakdown of academic impact, for papers by M Kriegler Breakdown of academic impact, for papers by Varada P. Rao Breakdown of academic impact, for papers by Vicki L. Schweickart Breakdown of academic impact, for papers by T Otsuka Breakdown of academic impact, for papers by Nirit Mor‐Vaknin Breakdown of academic impact, for papers by Tim Willinger Breakdown of academic impact, for papers by Pinaki P. Banerjee Breakdown of academic impact, for papers by Natalia Martín‐Orozco Breakdown of academic impact, for papers by Michael R. Rubira
Rankless by CCL
2026